世界のベルケイド市場予測（～2028年）：1.0 Mg注入、3.5Mg注入

• 英文タイトル：Global Velcade Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8987 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ベルケイド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のベルケイドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ベルケイド市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・1.0 Mg注入、3.5Mg注入 用途別セグメントは次のように区分されます。 ・多発性骨髄腫、マントル細胞リンパ腫 世界のベルケイド市場の主要な市場プレーヤーは以下のとおりです。 ・Johnson & Johnson、Takeda、Hospira、Ben Venue Laboratories、Xi'an Yangsen Pharmaceutical、XISUN、Wuhan Renfu Pharmaceutical、Nanjing Zhengda Tianqing Pharmaceutical、Beijing Shuanglu Pharmaceutical、Harbin Sanlian Pharmaceutical、Sinopharm Pharmaceutical、Shandong Luoxin Pharmaceutical Group、Shanxi Pude Pharmaceutical、Guangdong Lingnan Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ベルケイド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なベルケイドメーカーの企業概要、2019年～2022年までのベルケイドの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なベルケイドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ベルケイドの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのベルケイドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのベルケイド市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびベルケイドの産業チェーンを掲載しています。 ・第13、14、15章では、ベルケイドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、Takeda、Hospira、Ben Venue Laboratories、Xi'an Yangsen Pharmaceutical、XISUN、Wuhan Renfu Pharmaceutical、Nanjing Zhengda Tianqing Pharmaceutical、Beijing Shuanglu Pharmaceutical、Harbin Sanlian Pharmaceutical、Sinopharm Pharmaceutical、Shandong Luoxin Pharmaceutical Group、Shanxi Pude Pharmaceutical、Guangdong Lingnan Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：1.0 Mg注入、3.5Mg注入 ・用途別分析2017年-2028年：多発性骨髄腫、マントル細胞リンパ腫 ・ベルケイドの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ベルケイドのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ベルケイドのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ベルケイドの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ベルケイドの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Velcade market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Velcade market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Multiple Myeloma accounting for % of the Velcade global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 1.0 Mg Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Velcade include Johnson & Johnson, Takeda, Hospira, Ben Venue Laboratories, and Xi’an Yangsen Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Velcade market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
1.0 Mg Injection
3.5 Mg Injection
Market segment by Application can be divided into
Multiple Myeloma
Mantle Cell Lymphoma
The key market players for global Velcade market are listed below:
Johnson & Johnson
Takeda
Hospira
Ben Venue Laboratories
Xi’an Yangsen Pharmaceutical
XISUN
Wuhan Renfu Pharmaceutical
Nanjing Zhengda Tianqing Pharmaceutical
Beijing Shuanglu Pharmaceutical
Harbin Sanlian Pharmaceutical
Sinopharm Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Shanxi Pude Pharmaceutical
Guangdong Lingnan Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Velcade product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Velcade, with price, sales, revenue and global market share of Velcade from 2019 to 2022.
Chapter 3, the Velcade competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Velcade breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Velcade market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Velcade.
Chapter 13, 14, and 15, to describe Velcade sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Velcade Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Velcade Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 1.0 Mg Injection
1.2.3 3.5 Mg Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Velcade Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Multiple Myeloma
1.3.3 Mantle Cell Lymphoma
1.4 Global Velcade Market Size & Forecast
1.4.1 Global Velcade Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Velcade Sales in Volume (2017-2028)
1.4.3 Global Velcade Price (2017-2028)
1.5 Global Velcade Production Capacity Analysis
1.5.1 Global Velcade Total Production Capacity (2017-2028)
1.5.2 Global Velcade Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Velcade Market Drivers
1.6.2 Velcade Market Restraints
1.6.3 Velcade Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Velcade Product and Services
2.1.4 Johnson & Johnson Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Velcade Product and Services
2.2.4 Takeda Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hospira
2.3.1 Hospira Details
2.3.2 Hospira Major Business
2.3.3 Hospira Velcade Product and Services
2.3.4 Hospira Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ben Venue Laboratories
2.4.1 Ben Venue Laboratories Details
2.4.2 Ben Venue Laboratories Major Business
2.4.3 Ben Venue Laboratories Velcade Product and Services
2.4.4 Ben Venue Laboratories Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Xi’an Yangsen Pharmaceutical
2.5.1 Xi’an Yangsen Pharmaceutical Details
2.5.2 Xi’an Yangsen Pharmaceutical Major Business
2.5.3 Xi’an Yangsen Pharmaceutical Velcade Product and Services
2.5.4 Xi’an Yangsen Pharmaceutical Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 XISUN
2.6.1 XISUN Details
2.6.2 XISUN Major Business
2.6.3 XISUN Velcade Product and Services
2.6.4 XISUN Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Wuhan Renfu Pharmaceutical
2.7.1 Wuhan Renfu Pharmaceutical Details
2.7.2 Wuhan Renfu Pharmaceutical Major Business
2.7.3 Wuhan Renfu Pharmaceutical Velcade Product and Services
2.7.4 Wuhan Renfu Pharmaceutical Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Nanjing Zhengda Tianqing Pharmaceutical
2.8.1 Nanjing Zhengda Tianqing Pharmaceutical Details
2.8.2 Nanjing Zhengda Tianqing Pharmaceutical Major Business
2.8.3 Nanjing Zhengda Tianqing Pharmaceutical Velcade Product and Services
2.8.4 Nanjing Zhengda Tianqing Pharmaceutical Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Beijing Shuanglu Pharmaceutical
2.9.1 Beijing Shuanglu Pharmaceutical Details
2.9.2 Beijing Shuanglu Pharmaceutical Major Business
2.9.3 Beijing Shuanglu Pharmaceutical Velcade Product and Services
2.9.4 Beijing Shuanglu Pharmaceutical Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Harbin Sanlian Pharmaceutical
2.10.1 Harbin Sanlian Pharmaceutical Details
2.10.2 Harbin Sanlian Pharmaceutical Major Business
2.10.3 Harbin Sanlian Pharmaceutical Velcade Product and Services
2.10.4 Harbin Sanlian Pharmaceutical Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sinopharm Pharmaceutical
2.11.1 Sinopharm Pharmaceutical Details
2.11.2 Sinopharm Pharmaceutical Major Business
2.11.3 Sinopharm Pharmaceutical Velcade Product and Services
2.11.4 Sinopharm Pharmaceutical Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Shandong Luoxin Pharmaceutical Group
2.12.1 Shandong Luoxin Pharmaceutical Group Details
2.12.2 Shandong Luoxin Pharmaceutical Group Major Business
2.12.3 Shandong Luoxin Pharmaceutical Group Velcade Product and Services
2.12.4 Shandong Luoxin Pharmaceutical Group Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shanxi Pude Pharmaceutical
2.13.1 Shanxi Pude Pharmaceutical Details
2.13.2 Shanxi Pude Pharmaceutical Major Business
2.13.3 Shanxi Pude Pharmaceutical Velcade Product and Services
2.13.4 Shanxi Pude Pharmaceutical Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Guangdong Lingnan Pharmaceutical
2.14.1 Guangdong Lingnan Pharmaceutical Details
2.14.2 Guangdong Lingnan Pharmaceutical Major Business
2.14.3 Guangdong Lingnan Pharmaceutical Velcade Product and Services
2.14.4 Guangdong Lingnan Pharmaceutical Velcade Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Velcade Breakdown Data by Manufacturer
3.1 Global Velcade Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Velcade Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Velcade
3.4 Market Concentration Rate
3.4.1 Top 3 Velcade Manufacturer Market Share in 2021
3.4.2 Top 6 Velcade Manufacturer Market Share in 2021
3.5 Global Velcade Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Velcade Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Velcade Market Size by Region
4.1.1 Global Velcade Sales in Volume by Region (2017-2028)
4.1.2 Global Velcade Revenue by Region (2017-2028)
4.2 North America Velcade Revenue (2017-2028)
4.3 Europe Velcade Revenue (2017-2028)
4.4 Asia-Pacific Velcade Revenue (2017-2028)
4.5 South America Velcade Revenue (2017-2028)
4.6 Middle East and Africa Velcade Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Velcade Sales in Volume by Type (2017-2028)
5.2 Global Velcade Revenue by Type (2017-2028)
5.3 Global Velcade Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Velcade Sales in Volume by Application (2017-2028)
6.2 Global Velcade Revenue by Application (2017-2028)
6.3 Global Velcade Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Velcade Sales by Type (2017-2028)
7.2 North America Velcade Sales by Application (2017-2028)
7.3 North America Velcade Market Size by Country
7.3.1 North America Velcade Sales in Volume by Country (2017-2028)
7.3.2 North America Velcade Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Velcade Sales by Type (2017-2028)
8.2 Europe Velcade Sales by Application (2017-2028)
8.3 Europe Velcade Market Size by Country
8.3.1 Europe Velcade Sales in Volume by Country (2017-2028)
8.3.2 Europe Velcade Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Velcade Sales by Type (2017-2028)
9.2 Asia-Pacific Velcade Sales by Application (2017-2028)
9.3 Asia-Pacific Velcade Market Size by Region
9.3.1 Asia-Pacific Velcade Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Velcade Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Velcade Sales by Type (2017-2028)
10.2 South America Velcade Sales by Application (2017-2028)
10.3 South America Velcade Market Size by Country
10.3.1 South America Velcade Sales in Volume by Country (2017-2028)
10.3.2 South America Velcade Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Velcade Sales by Type (2017-2028)
11.2 Middle East & Africa Velcade Sales by Application (2017-2028)
11.3 Middle East & Africa Velcade Market Size by Country
11.3.1 Middle East & Africa Velcade Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Velcade Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Velcade and Key Manufacturers
12.2 Manufacturing Costs Percentage of Velcade
12.3 Velcade Production Process
12.4 Velcade Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Velcade Typical Distributors
13.3 Velcade Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---